What Can We Learn From Celularity Inc. (CELU)’s Valuation Ratios?

0
76

Celularity Inc. (NASDAQ:CELU) finished Friday with an addition of $0.05 to close at $1.29, an upside of 4.03 percent. An average of 399,380 shares of common stock have been traded in the last five days. There was a gain of $0.1200 in the past week, and it reached a new high 21 times over the past 12 months. The last 20 days have seen an average of 407,010 shares traded, while the 50-day average volume stands at 405,288.

CELU stock has decreased by -24.56% in the last month. The company shares reached their 1-month lowest point of $1.0490 on 12/28/22. With the stock rallying to its 52-week high on 04/28/22, shares of the company touched a low of $1.05 and a high of $13.19 in 52 weeks. It has reached a new high 21 times so far this year and lost -74.80% or -$3.8300 in price. In spite of this, the price is down -90.22% from the 52-week high.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Valuation Metrics

Celularity Inc. (CELU) stock’s beta is 0.35. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 10.18, the price-to-book (PB) ratio at 1.12.

Financial Health

The quick ratio of Celularity Inc. for the three months ended September 29 was 0.80, and the current ratio was 0.90, indicating that the company is not able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.24 for the quarter ending September 29. Its gross profit as reported stood at $11.68 million compared to revenue of $21.34 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Celularity Inc.’s return on assets was -3.30%.

Earnings Surprise

In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $4.8 million in the quarter, while revenues of $47.83 million were shrunk -940.42%. The analyst consensus anticipated Celularity Inc.’s latest quarter earnings to come in at -$0.26 per share, but it turned out to be $0.03, a 111.50% surprise. For the quarter, EBITDA amounted to -$3.25 million. Shareholders own equity worth $145.01 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Celularity Inc. (CELU) price momentum. RSI 9-day as of the close on 30 December was 45.65%, suggesting the stock is Neutral, with historical volatility in this time frame at 134.59%.

As of today, CELU’s price is $1.1740 +10.26% or $0.1200 from its 5-day moving average. CELU is currently trading -27.93% lower than its 20-day SMA and -58.79% lower than its 100-day SMA. However, the stock’s current price level is -40.00% below the SMA50 and -81.81% below the SMA200.

The stochastic %K and %D were 23.44% and 13.96%, respectively, and the average true range (ATR) was 0.1521. With the 14-day stochastic at 34.38% and the average true range at 0.1611, the RSI (14) stands at 41.53%. The stock has reached 0.0178 on the 9-day MACD Oscillator while the 14-day reading was at -0.1017.

Analyst Ratings

Oppenheimer downgraded Celularity Inc. (NASDAQ: CELU) to a a Perform rating in its most recent analyst report. Previously, the stock was rated as an Outperform. The consensus rating for Celularity Inc. (CELU) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell CELU, while 2 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 2 others rate it as a “buy”.

What is CELU’s price target for the next 12 months?

Analysts predict a range of price targets between $5.00 and $15.00, with a median target of $10.50. Taking a look at these predictions, the average price target given by analysts for Celularity Inc. (CELU) stock is $10.25.

LEAVE A REPLY

Please enter your comment!
Please enter your name here